Subscribe to Optik:

Sales growth and new appointments at Luxottica

Luxottica reported sales of CA$8.2 billion for the first nine months of 2014, a 2.1% increase over the same period last year.

Growth was driven by the North American market, with an increase in wholesale sales of 11% and retail sales of 4.3%. Sales rose 30% in China, Brazil, India, and the Middle East.

In addition, the company confirmed that Massimo Vian will step into the role of acting CEO until the arrival of Adil Mehboob-Khan in January 2015. After that, the latter will hold the position of co-CEO of markets, and Massimo Vian will manage the products and operations sector. Finally, the Board of Directors appointed Stefano Grassi as the new financial officer, replacing Enrico Cavatorta, who recently resigned.

For more information: http://www.luxottica.com/sites/luxottica.com/files/2014_10_29_-_luxottica_-_3q_2014_results_-_eng.pdf

Highlights from Optik Magazine

The Kick off CE course is about Social media
Discover the A+ Method (Assess, Acknowledge, Adjust) to build trust,
Specsavers marks milestone with the reopening and expansion of its
A new study shows B vitamins and choline may protect
Discover the Blackfin Cobalt 1083 titanium frame: ultra-light, hypoallergenic, Made
Costa Sunglasses has expanded its lifestyle collection with Trades and
From Stadium to Street: Three Frames That Embody Patrick Mahomes
Crafted in stainless steel with hand-painted accents, Chiavari’s silhouette is
Discover the latest kids’ and teens’ eyewear trends—frames, lens tech,
Discover the A+ Method (Assess, Acknowledge, Adjust) to build trust,
An enhanced Myopia Tool Kit is now available from the
Learn how eyewearprofessionals Kim Manias and Christine Zeggil are shaping
Three ways frame quality vs. quantity can be the difference
A new study shows B vitamins and choline may protect
KAIST researchers may have unlocked retina regeneration by blocking the
A study in ACS Nano shows that gold nanoparticles may
Fighting Blindness Canada is sharing clinical trial updates on two
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.